Northpond Ventures GP, LLC (0001867470)

State location: MD | State of Inc.: DE Business Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 240-800-1200 Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Camp4 Therapeutics Corp 0001736730 2024-10-10 10 percent owner Vigil Neuroscience, Inc. 0001827087 2022-01-06 10 percent owner IsoPlexis Corp 0001615055 2021-10-07 10 percent owner DICE Therapeutics, Inc. 0001645569 2021-09-14 10 percent owner Codex DNA, Inc. Current Name:Telesis Bio Inc. 0001850079 2021-06-17 10 percent owner

Items 1 - 27

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
D	2023-06-22		DICE Therapeutics, Inc.	4	S-Sale	--I	523503.0000	166293.0000	2	0001645569	Common Stock
D	2023-06-22		DICE Therapeutics, Inc.	4	S-Sale	--I	1969368.0000	633707.0000	1	0001645569	Common Stock
A	2023-06-05		Telesis Bio Inc.	4	A-Award	--I	1692549.0000	1692549.0000	3	0001850079	Short-Term Warrants
A	2023-06-05		Telesis Bio Inc.	4	A-Award	--I	3385097.0000	3385097.0000	2	0001850079	Long-Term Warrants
A	2023-06-05		Telesis Bio Inc.	4	A-Award	--I	80000.0000	3385097.0000	1	0001850079	Redeemable Convertible Preferred Stock
D	2022-01-11		Vigil Neuroscience, Inc.	4	C-Conversion	--I	1027978.0000	0.0000	5	0001827087	Series B Preferred Stock
D	2022-01-11		Vigil Neuroscience, Inc.	4	C-Conversion	--I	2831520.0000	0.0000	4	0001827087	Series A Preferred Stock
A	2022-01-11		Vigil Neuroscience, Inc.	4	P-Purchase	--I	355000.0000	1382978.0000	3	0001827087	Common Stock
A	2022-01-11		Vigil Neuroscience, Inc.	4	C-Conversion	--I	1027978.0000	1027978.0000	2	0001827087	Common Stock
A	2022-01-11		Vigil Neuroscience, Inc.	4	C-Conversion	--I	2831520.0000	2831520.0000	1	0001827087	Common Stock
D	2021-09-17		DICE Therapeutics, Inc.	4	C-Conversion	--I	867687.0000	0.0000	5	0001645569	Series C Convertible Preferred Stock
D	2021-09-17		DICE Therapeutics, Inc.	4	C-Conversion	--I	454796.0000	0.0000	6	0001645569	Series C-1 Convertible Preferred Stock
D	2021-09-17		DICE Therapeutics, Inc.	4	C-Conversion	--I	1735388.0000	0.0000	4	0001645569	Series B Convertible Preferred Stock
A	2021-09-17		DICE Therapeutics, Inc.	4	P-Purchase	--I	235000.0000	3292871.0000	3	0001645569	Common Stock
A	2021-09-17		DICE Therapeutics, Inc.	4	C-Conversion	--I	454796.0000	3057871.0000	2	0001645569	Common Stock
A	2021-09-17		DICE Therapeutics, Inc.	4	C-Conversion	--I	2603075.0000	2603075.0000	1	0001645569	Common Stock
D	2021-06-22		Codex DNA, Inc.	4	C-Conversion	--I	4160529.0000	0.0000	4	0001850079	Series A-1 Preferred Stock
D	2021-06-22		Codex DNA, Inc.	4	C-Conversion	--I	5214851.0000	0.0000	3	0001850079	Series A Preferred Stock
A	2021-06-22		Codex DNA, Inc.	4	P-Purchase	--I	468750.0000	9844130.0000	2	0001850079	Common Stock
A	2021-06-22		Codex DNA, Inc.	4	C-Conversion	--I	9375380.0000	9375380.0000	1	0001850079	Common Stock
-	-		Codex DNA, Inc.	3	-	--I			1	0001850079	Series A Preferred Stock
-	-		Vigil Neuroscience, Inc.	3	-	--I			1	0001827087	Series A Preferred Stock
-	-		Vigil Neuroscience, Inc.	3	-	--I			2	0001827087	Series B Preferred Stock
-	-		DICE Therapeutics, Inc.	3	-	--I			3	0001645569	Series C-1 Convertible Preferred Stock
-	-		DICE Therapeutics, Inc.	3	-	--I			2	0001645569	Series C Convertible Preferred Stock
-	-		DICE Therapeutics, Inc.	3	-	--I			1	0001645569	Series B Convertible Preferred Stock
-	-		Codex DNA, Inc.	3	-	--I			2	0001850079	Series A-1 Preferred Stock

http://www.sec.gov/cgi-bin/own-disp

---